is similar to treatment with ACEIs and ARBs and diminishes the anti-inflammatory effects of Ang II in different tissues to manage arthritis, renal, cardiovascular, pulmonary, and hepatic disease. This evidence concerns the gene AGT and arthritic joint disease.